托吡酯、丙戊酸钠对癫痫患儿体质量及糖代谢指标的影响
发布时间:2018-04-08 22:25
本文选题:托吡酯 切入点:丙戊酸钠 出处:《广西医科大学》2012年硕士论文
【摘要】:目的观察托吡酯(TPM)与丙戊酸钠(VPA)对癫痫患儿体质量及糖代谢指标的影响。 方法选择首次诊断癫痫TPM或VPA单药治疗的患儿各30例,分别于治疗前、治疗3个月和6个月进行体质量、空腹血糖、空腹胰岛素、胰岛素抵抗(IR)指数、瘦素、脂联素、瘦素/脂联素(L/A)测定,行TPM、VPA治疗前后自身对照研究。 结果TPM组:治疗3个月的患儿空腹胰岛素水平、IR指数、瘦素水平、L/A较治疗前均明显降低(均P0.01),体质量和脂联素水平变化不明显(均P0.05);治疗6个月的患儿空腹胰岛素水平、IR指数、瘦素水平、L/A较治疗3个月时亦明显降低(均P0.01),体质量较治疗前、治疗3个月时均明显增高(P0.05),但脂联素水平较治疗前明显增高(P0.01): TPM治疗前后空腹血糖水平无显著区别(P0.05)。 VPA组:治疗3个月的患儿体质量、空腹胰岛素水平、IR指数、瘦素水平、L/A较治疗前均明显升高(均P0.05)但脂联素水平较治疗前明显降低(P0.01);VPA治疗6个月的患儿体质量、瘦素水平、L/A较治疗3个月时亦明显升高(均P0.05)而脂联素水平较治疗3个月时下降更明显(P0.01),空腹胰岛素水平、IR指数较治疗前、治疗3个月时均明显降低(均P 0.01); VPA治疗前后空腹血糖水平无显著区别(P0.05)。 结论(1)TPM治疗后使癫痫患儿体质量增长缓慢,而不是真正的体质量下降。 (2)VPA治疗后使癫痫患儿体质量增加。 (3) TPM、VPA治疗后可引起糖代谢指标的变化。(4) TPM、PA治疗后对血糖水平无显著影响。
[Abstract]:Objective to observe the effects of topiramate (TPM) and sodium valproate (VPA) on body mass and glucose metabolism in epileptic children.Methods 30 children with epilepsy treated with TPM or VPA for the first time were given body mass, fasting blood glucose, fasting insulin, insulin resistance index, leptin and adiponectin before treatment for 3 and 6 months, respectively.Leptin / adiponectin L / A was measured and self-controlled study was performed before and after treatment with TPM VPA.Results in TPM group, the fasting insulin level and IR index, leptin level and L / A were significantly decreased after 3 months of treatment (all P 0.01), the body weight and adiponectin levels were not changed significantly (all P 0.05), and the fasting insulin level of 6 months after treatment was significantly lower than that of before treatment (P 0.05), and no significant changes were found in the body mass and adiponectin levels (P 0.05).Leptin level was significantly lower than that at 3 months after treatment (all P0.01A, body weight was higher than that before treatment, P0.05A was significantly higher than that before treatment, but adiponectin level was significantly higher than that before and after treatment. There was no significant difference in fasting blood glucose level before and after treatment with TPM.In VPA group, the body mass, fasting insulin level, IR index and leptin level were significantly higher than those before treatment (all P0.05), but adiponectin level was significantly lower than that before treatment.The levels of leptin, L / A and adiponectin were significantly higher than those at 3 months after treatment (all P 0.05), and the levels of adiponectin were significantly lower than those at 3 months after treatment (P 0.01), and the fasting insulin level and IR index were higher than those before treatment.After 3 months of treatment, the level of fasting blood glucose decreased significantly (all P 0.01), and there was no significant difference in fasting blood glucose level before and after treatment with VPA (P 0.05).Conclusion the body mass of epileptic children increased slowly but not the real body mass decreased after TPM treatment.After treatment with VPA, the body mass of epileptic children was increased.(3) TPMN VPA could cause the change of glucose metabolism index after treatment. 4) TPMN PA had no significant effect on blood glucose level after treatment.
【学位授予单位】:广西医科大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R742.1
【参考文献】
相关期刊论文 前7条
1 陈峰;黄绍平;;托吡酯与丙戊酸钠对婴幼儿癫痫体重及相关代谢指标的影响[J];中国儿童保健杂志;2009年06期
2 孙建英;迟兆富;吴伟;刘学伍;;妥泰对海人酸致沲大鼠海马神经元线粒体损伤的保护作用[J];中国实用神经疾病杂志;2006年01期
3 孙仁山;陈晓红;李文维;赵丽蓉;;薄芝糖肽的临床应用[J];时珍国医国药;2009年08期
4 张彦;朱凤莲;郭学鹏;;神经生长因子和托吡酯对红藻氨酸致痫大鼠海马神经细胞caspase-3表达的影响[J];中国康复医学杂志;2007年02期
5 金瑞峰,孙若鹏,徐向平;多药耐药基因在慢性癫沲大鼠中的表达及托吡酯对其表达的影响[J];中华儿科杂志;2005年10期
6 施荣富;王克玲;李清华;郑华城;杨华芳;唐红霞;孙素真;王丽辉;田杰;;托吡酯治疗后癫vN患儿体重和血浆甘丙肽的变化[J];中华儿科杂志;2007年03期
7 黎明 ,吴从愿 ,张葵 ,詹志伟 ,李晓光 ,甘利虹 ,杨静;血清瘦素水平与胰岛素原、真胰岛素及胰岛素敏感性的关系[J];中华内科杂志;2002年11期
,本文编号:1723633
本文链接:https://www.wllwen.com/yixuelunwen/eklw/1723633.html
最近更新
教材专著